EGFRvIII peptide PEPvIII
CAS No. 129112-17-0
EGFRvIII peptide PEPvIII ( )
Catalog No. M30288 CAS No. 129112-17-0
PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameEGFRvIII peptide PEPvIII
-
NoteResearch use only, not for human use.
-
Brief DescriptionPEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
-
DescriptionPEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number129112-17-0
-
Formula Weight1634.8
-
Molecular FormulaC70H111N19O24S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Schmittling RJ, et al. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines. J Immunol Methods. 2008 Nov 30;339(1):74-81.
molnova catalog
related products
-
Prunasin
Prunasin is a kind of enzyme inhibitors.
-
Fmoc-Thr(GlcNAc(Ac)3...
This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis.
-
TAT TFA (191936-91-1...
TAT TFA (YGRKKRRQRRR) is derived from human immunodeficiency virus (hiv-1) transcription reverse activator TAT, is a cell penetrating peptide.